Combioxin, a clinical phase biotechnology company based in Epalinges, Switzerland, has signed a worldwide commercial license agreement with Eagle Pharmaceuticals, a fully integrated pharmaceutical company based in Woodcliff Lake, NY, USA. Under the terms of the agreement, Eagle Pharmaceuticals will be solely responsible for the continued clinical development of CAL02 and will provide an upfront payment, […]
La Mobilière, TX Group, Ringier and General Atlantic form a joint venture to create a digital marketplace group. The CEO of the joint venture will be Gilles Despas, currently CEO of the Scout24 Switzerland
VectivBio Holding, clinical-stage biopharmaceutical company specialising in novel transformational treatments for severe rare conditions announced the acquisition of Comet Therapeutics, a biotechnology company that has been developing drugs to address previously untreatable inherited metabolic diseases.
Dekra, the German vehicle inspection company, announced the acquisition of a minority stake in Spearhead, a Swiss company specializing in data analytics for automotive claims and vehicle lifecycle management. Homburger acted as legal counsel to
The Renaissance Investment Foundation has become a long-term majority shareholder in the capital of bb trading werbeartikel, the distributor of promotional items and customer gifts in Switzerland. CMS Switzerland provided comprehensive legal and tax
Thommen-Furler – the parent company of a group specializing in the fields of distribution of chemicals, specialties and lubricants, environmental technology and the disposal and recycling of industrial and hazardous waste with a turnover of approx,
Atlas Antibodies, a global developer of advanced reagents for biomedical research based in Sweden, has agreed to acquire Evitria Group from its shareholders. The transaction closed on August 5, 2021. Vischer advised the sellers on this
The Swiss e-commerce agency and software house specializing in the design, development and operation of e-commerce solutions for SMEs, MySign has becomes part of the German Allgeier Group. The IT and software services company Allgeier
WuXi STA, a subsidiary of WuXi AppTec, a pharmaceutical development and manufacturing capability and technology platform company, whose shares are listed on the Shanghai Stock Exchange and the Hong Kong Stock Exchange, completed the acquisition
A consortium consisting of German carmaker and pioneer in the area of climate-neutral mobility Volkswagen (66%), the English investment fund Attestor Limited (27%) and Dutch Pon Holdings B.V. (7%) submitted a takeover bid to the French listed
